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Abstract
Background: A limiting factor of cDNA microarray technology is the need for a substantial
amount of RNA per labeling reaction. Thus, 20–200 micro-grams total RNA or 0.5–2 micro-grams
poly (A) RNA is typically required for monitoring gene expression. In addition, gene expression
profiles from large, heterogeneous cell populations provide complex patterns from which biological
data for the target cells may be difficult to extract. In this study, we chose to investigate a widely
used mRNA amplification protocol that allows gene expression studies to be performed on
samples with limited starting material. We present a quantitative study of the variation and noise
present in our data set obtained from experiments with either amplified or non-amplified material.
Results: Using analysis of variance (ANOVA) and multiple hypothesis testing, we estimated the
impact of amplification on the preservation of gene expression ratios. Both methods showed that
the gene expression ratios were not completely preserved between amplified and non-amplified
material. We also compared the expression ratios between the two cell lines for the amplified
material with expression ratios between the two cell lines for the non-amplified material for each
gene. With the aid of multiple t-testing with a false discovery rate of 5%, we found that 10% of the
genes investigated showed significantly different expression ratios.
Conclusion: Although the ratios were not fully preserved, amplification may prove to be
extremely useful with respect to characterizing low expressing genes.
Background
The substantial amount of RNA required for expression
analysis is a limiting factor for the cDNA microarray tech-
nology in a number of potentially important applications.
Two main approaches, signal amplification and global
mRNA amplification, have been developed to overcome
this obstacle. Signal amplification, such as dendrimer
technology [1] and tyramide signal amplification (TSA)
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mRNA molecule. Global mRNA amplification has the
purpose of increasing the number of available transcript
equivalents for sufficient labeling from a limited starting
amount. In current implementations, mRNA amplifica-
tion techniques require less RNA than those based on sig-
nal amplification.
Van Gelder et al. [3] devised a multistep strategy to ampli-
fy mRNA from limited quantities of cDNA in studies of
gene expression. Their method is commonly referred to in
the literature as the Eberwine method. The general steps
involve reverse transcription of mRNA with an oligo dT-
primer bearing a T7-promoter site. After synthesis of dou-
ble stranded cDNA, antisense RNA was transcribed by the
T7-polymerase in an in vitro transcription reaction. Two
recent reports have described detailed protocols for
mRNA amplification used with microarray gene expres-
sion profiling [4,5]. We have followed the optimized pro-
tocol presented by Baugh et al. [5] which has retained the
basis of the Eberwine strategy, but where they have intro-
duced some modifications in order to reduce undesired
products. The protocol involves two rounds of amplifica-
tion, which we found to be suitable for further studies as
the output of aRNA obtained from 0.2 µg total RNA was
sufficient for several hybridizations. Although both re-
ports demonstrate the potential of mRNA amplification, it
is clear that the challenge lies in a detailed comparison of
data sets obtained from amplified samples versus non-
amplified samples to estimate the consistency of the re-
sults. This is a critical step in order to validate the use of
microarray data obtained from amplified material
quantitatively.
Global mRNA amplification has been employed in a
range of applications, including more recent studies
where microarrays have been utilized for expression pro-
filing [6–9]. An optimal upscaling of mRNA that intro-
duced minimal systematic biases, would maintain the
relative transcript abundance present in the initial mRNA
sample. Examinations of the transcript level preservation
through mRNA amplification procedures have so far in-
volved Northern blot confirmation using a limited
number of genes [10], dot blot differential screening of se-
lected cDNAs using probes synthesized from poly(A) RNA
or aRNA [11], the use of internal RNA standards [12], hi-
erarchical clustering to compare consistency of outliers
[4], validation by quantitative RT-PCR [13] or compari-
sons of ratio/intensity distribution of the entire gene set,
and subgroups determined by gene abundance [8].
Based on microarray analysis, estimates of ratio preserva-
tion through mRNA amplification have been assessed
from correlation between ratio profiles from amplified
aRNA and the total RNA [4,8,13–15]. The studies referred
to here have applied 1–3 rounds of amplification. Wang
et al. [4] presented an informative study, although limit-
ed, as they only focused on the maintenance between two
RNA sources of differentially expressed genes or "out-
liers". A relatively stringent filtering criterion was used and
outliers determined by total RNA hybridization experi-
ments were used as controls. By applying hierarchical
clustering, they identified reproducible outliers across ar-
rays of variable experimental conditions. When aRNA was
generated from 0.25–3.0 µg of total RNA, 85–92% of the
outliers from the control experiments were also identified
as differentially expressed genes after aRNA hybridization
analysis. Scheidl et al. [8] presented all genes in common
between aRNA and total RNA, and not only the outliers.
Through a series of plots of pre-processed data, they indi-
cated the degree of preservation that could be expected
under the experimental conditions applied. Although the
intensity levels were not preserved, the relative abundanc-
es of transcripts were maintained, giving rise to a relatively
high correlation factor (0.84). Pearson correlation coeffi-
cients of ratio-to-ratio measurements were calculated ac-
cording to mean intensities of the corresponding genes,
showing decreased coefficients as intensities approached
background levels. Zhao et al. [15] also obtained a similar
average correlation coefficient (0.82), when using an op-
timized protocol as did Feldman et al. [16], who obtained
a correlation coefficient of 0.8. Hu et al. [14] and Puskás
et al. [13] took the outcome of amplification one step fur-
ther and pointed out the observation that additional
genes were detected in arrays hybridized with amplified
material. Absolute intensity levels were elevated on arrays
hybridized with labeled aRNA and as a consequence more
genes were registered. Hu et al. [14] selected a few of these
genes. They confirmed by other molecular techniques that
these genes were in fact expressed in the cells and not the
result of unspecific binding or artifacts. This indicated that
amplified RNA was more sensitive to low abundance tran-
scripts than the standard method using total RNA. Due to
improved signal to background levels using aRNA, Feld-
man et al. [16] not only scored more genes on arrays with
amplified material, but also observed a doubling in the
number of outliers. Hence, within the limits investigated
so far, the general conclusion is that microarray data from
amplified material is comparable to non-amplified mate-
rial, but there is a slight decrease in correlation coefficients
reflecting changes in transcript ratios.
In this study, we refer to total RNA as the "true" standard.
However, this is not necessarily correct. Using ANOVA
analysis, Smith et al. [17] found that the variation between
total RNA replicates was highly significant. Other molecu-
lar techniques could be used to verify the reliability of our
total RNA standard, but for the moment few reasonable
approaches are available for high throughput verification.
Quantitative real time PCR is not suited to queryPage 2 of 13
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itself to query the number of experiments performed in
this report. Also, the publicly available SAGE data may not
correspond to the samples used in microarray experi-
ments, with respect to e.g. transcript representation and
priming method.
Quantitative studies of transcript ratio variations between
amplified RNA and total RNA are few, and no consensus
with respect to the sources of the observed results have
been obtained. The high degree of correlation between in-
dependent amplifications from the same RNA indicates
that repetition of the amplification procedure does not
appear to be the source of variation [5,13,15,18]. Never-
theless, it is clear that microarray hybridizations are affect-
ed by substantial variability even under controlled
conditions. Previously reported correlation coefficients
between total RNA and aRNA profiles represent the total
amount of variation, including noise, without quantifica-
tion of the variation due to the amplification procedure it-
self. Our aim therefore, was to perform further
comparisons of microarray data sets obtained from ampli-
fied and non-amplified material by introducing an ANO-
VA based statistical design where the goal was to isolate
the variation in gene expression data due to amplification
from other sources of variation present in the data set. In
addition we used a multiple t-test to identify the genes
that displayed consistent ratios (referred to as the "con-
servative set") from those that contributed to ratio varia-
tion due to the amplification. To find the overall effect of
amplification on the ratios, we compared Signal to Noise
Ratios (SNRs) including variations due to amplification
or not. This was done both for the total and "conservative
set".
Results and Discussion
The goal of this study is to evaluate if ratios are preserved
by the amplification protocol under study. We assess this
question by examining data of observed intensities and
ratios between two cell lines in cDNA microarray experi-
ments using non-amplified material and amplified mate-
rial. Two different cell lines (MT-1 and U2OS) are
considered since it is impossible to hybridize non-ampli-
fied and amplified material on the same array. The exper-
imental design is presented in Figure 1, and explained in
the Methods Section. The design consists of four hybridi-
zations of non-amplified material and eight hybridiza-
tions of amplified material.
Preservation of ratios can be addressed by performing
multiple hypothesis testing by comparing ratios between
the two cell lines for the amplified material with ratios be-
tween the two cell lines for the non-amplified material for
each gene. This strategy can lead to a division of the total
number of genes under study into a set of genes where the
ratio is clearly preserved (called the "conservative set"), a
set of genes where the ratio is clearly not preserved (called
the "rejected set"), and a set of genes where the conclusion
about ratio preservation is unclear (called the "undeter-
mined set"). This strategy has been investigated, but since
the size of the undetermined set can be substantial the
strategy is not completely satisfactory.
We have chosen to address the question of preservation of
ratios on an overall level with the aid of a statistical anal-
ysis of variance model. An additional motivation for using
such a model is that we are also interested in investigating
if the variability caused by the amplification protocol is
large compared with the total variability in the experi-
ments. We found many sources of variation present in the
cDNA experiments; variation between amplified and non-
amplified material (protocol, P), between the two differ-
ent cell lines (C), between different batches of each cell
line, (B) between different arrays (A), between the two dif-
ferent florescent dyes (D), between different spots (AG),
between different genes (G) and combinations thereof.
Based on this, an experimental design was developed and
an ANOVA-based statistical model was constructed. From
estimates of the parameters present in the ANOVA-model,
a Signal to Noise Ratio (SNR) evaluation criterion was
constructed. The ANOVA-model is based on modelling
normalized log2-intensities, but SNR evaluations are cal-
culated with focus on ratios. The details are found in the
Methods Section.
Results on the total data set
Data from the cDNA experiments were analysed and pre-
processed as described in the Methods section. See Table
1 and Table 2 for details on filtered genes. The experi-
ments using aRNA produced superior hybridization qual-
ity. This was reflected in the lower number of filtered
genes per array compared with the total RNA hybridiza-
tions. On average, 35% of the genes were filtered from ar-
rays hybridized with amplified material, versus 63% of
the genes filtered from arrays hybridized with non-ampli-
fied material (Table 2). As a measurement of array quality,
Pearson correlations were calculated between the different
arrays. For the amplified arrays, 28 pairs of arrays can be
formed, and the average correlation coefficient was 0.90
(ranging from 0.82 to 0.96). For the non-amplified arrays,
six pairs of arrays can be formed, and the average correla-
tion coefficient was 0.87 (ranging from 0.82–0.95 for the
six pairs). The average correlation between amplified and
non-amplified arrays was 0.79 (ranging from 0.71 to
0.84).
The ANOVA-model was fitted to the filtered data set of
10759 genes. Parameter estimates in the ANOVA-model
are found in Table 3. To sum up, the main findings of Ta-
ble 3 is a comparison of the different sources ofPage 3 of 13
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and in interaction between array and dye, AD, were
small. This meant that there was a low variability between
samples from the same cell line and that the different dyes
had about the same effect for different arrays. The estimat-
ed variability in the interaction between gene and dye,
DG, was small, which meant that there was no promi-
nent dye effect. The unexplained modeling and measure-
ment error, denoted σε, was estimated to be moderate,
and the estimated variability in the cell line, gene, and
protocol interaction, CGP, was comparable to ε. This
implies that the amplification did not preserve the ratios
perfectly. The estimate of the variability of the arrays (hy-
bridization effect), A, was larger than the estimated cell
line, gene, and protocol interaction. The estimated varia-
bility due to the spot effect, AG, was as expected quite
large. The estimated variability of the interaction between
cell line and gene, CG, was large, and this was reasona-
ble, since each cell line had a unique gene expression pro-
file. Also the estimated variability in the gene-protocol
interaction, GP, was large, indicating that the magnitude
of the intensities was not amplified equally for all genes.
Figure 1
Experimental design. For a particular cell line, the material was divided into six batches; two batches of non-amplified RNA 
were directly labeled (white shapes) and four batches of diluted total RNA were amplified before labeling (grey shapes). These 
batches were split in two and labeled Cy5 (red) or Cy3 (green). In total, four array experiments were based on non-amplified 
material, and eight experiments were based on amplified material.
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very large, since the genes obviously had different expres-
sion levels. The ranking of size of the estimated random
effects are AD < B < DG < ε < CGP < A < AG
< CG < GP < G.
Results on the evaluation of the SNR-criterion are found
in Table 4. The SNR was reduced from 9.91 to 5.22 by the
inclusion of the cell line, gene, and protocol interaction.
Thus, the overall implication of the amplification was a
doubling of relative noise in the experiments. From this
we can conclude that not all the ratios are preserved when
looking at the total data set of 10759 genes. 6318 of the
10759 genes are present both on arrays with amplified
and on arrays with unamplified material. Only these 6318
genes contributed directly in the estimation of the param-
eters measuring the variability caused by amplification
(e.g. the variability in the cell line, gene, and protocol
interaction). The other 10759-6318 = 4441 genes were
useful because they contributed to the estimation of the
other parameters of the model.
Results on the "conservative set"
Multiple hypothesis testing was performed to divide the
total data set into a "conservative set", a "rejected set" and
an "undetermined set". To be able to assess the variability
in the gene expression ratios, we only considered genes
where the number of observations in each group (ampli-
fied versus non-amplified) was at least three. This was true
for 4331 of the 10759 genes.
Table 1: Overview of filtered genes.
Description Number of genes
1Genes on an array 12497 (100%)
2Genes filtered out from all arrays 1738 (14%)
3Total number of genes after filtering 10759 (86%)
4Genes only detected in non-amplified material (at least one array) 64 (0.5%)
5Genes only detected in amplified material (at least one array) 4377 (35%)
6Genes detected for both groups 6318 (50.5%)
1Number of genes printed on an array. 2Genes not detected on any of the twelve arrays. 3Genes with signals on at least on array. 4Genes that were 
filtered out from all arrays with amplified material, but present on at least one array with non-amplified material. 5Genes that were filtered out from 
all arrays with non-amplified material, but present on at least one array with amplified material. 6Number of genes that were detected both in arrays 
with non-amplified material and in arrays with amplified material. These genes are again split into two groups; one with genes fulfilling the criterion 
of 3 observations in each group (4331 genes); and one with those not fulfilling this criterion (1987 genes).
Table 2: Filtering per array.
Arrays hybridized with amplified material Arrays hybridized with non-amplified material
Array 
number
1 2 5 6 7 9 10 11 3 4 8 12
Genes 
flagged by 
Genepix
5192 2155 1007 2152 3151 2209 3212 1073 4750 4909 2903 4374
41.55% 17025% 8.06% 17.22% 25.21% 17.68% 25.70% 8.59% 38.01% 39.28% 23.23% 35.00%
Genes 
flagged 
manually
15 1 3 5 2 6 10 1 116 15 4223 16
0.12% 0.008% 0.024% 0.04% 0.016% 0.048% 0.08% 0.008% 0.93% 0.12% 33.79% 0.13%
Additionally 
Filtered by 
(spot-back-
ground) / 
background 
> 1
2078 1621 1055 2081 2081 2033 1680 2596 3226 2223 2117 2521
16.63% 12.97% 8.44% 16.65% 16.15% 16.27% 13.44% 20.77% 25.81% 17.79% 16.94% 20.17%
Sum 7285 3777 2065 4238 5171 4238 4902 3670 8092 7147 9243 6911
58.30% 30.22% 16.52% 33.91% 41.38% 33.40% 39.22% 29.37% 64.75% 57.19% 73.96% 55.30%
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did not reject the hypothesis of equal expression between
the two protocols. Starting with the full set of 4331 genes,
we removed all genes with p-values less than 0.1 from the
t-test assuming unequal variances for the amplified and
non-amplified material for each gene (1376 genes). In ad-
dition, we removed genes with p-values less than 0.1
when performing a two-sample t-test assuming equal
variances for the amplified and non-amplified material
for each gene (234 more genes subtracted from the set).
This led to a "conservative set" of 2721 genes (2721/4331
= 63% of the genes investigated).
2) We defined a "rejected set" of genes for which we reject-
ed the hypothesis of equal expression, and thus found the
selected genes not to be consistently expressed between
the amplified and the non-amplified material. We rejected
hypotheses based on adjusted p-values from the two-sam-
ple t-test using the Benjamini-Hochberg multiple testing
procedure [19], as implemented in the multtest package
in the statistical language R. R packages for use with cDNA
microarray data are described in Dudoit et al. [20]. Using
a cut-off for these adjusted p-values of 0.01, led to a list of
154 genes. The expected false discovery rate (proportion
of false positives) in this list was estimated to be 1%.
3) The remaining genes (1456 genes) were not classified
as "conservative" nor "rejected" and we will refer to them
as the "undetermined set".
The plot in Figure 2A shows the difference between the
amplified and the non-amplified material for the log2-ra-
tio of the two cell-lines vs. the p-value for each of the 4331
genes. Small p-values are mainly found for large differenc-
es, but large differences with high p-values and small dif-
ferences with small p-values also exist. The plot in Figure
2B compares the ratio distribution of the 4331 genes ob-
tained with amplified and non-amplified material. For
both plots the genes in the "conservative set" are in green,
the genes in the "rejected set" are in red, and the genes in
the "undetermined set" are in black.
The "conservative set" of genes was investigated further
using our ANOVA procedure, and parameter estimates are
presented in Table 3. The estimated variability for the
"conservative set" had the same ranking as the total data
set with one exception. The interaction between cell line,
gene and protocol, CGP, was considerably lower in the
"conservative set". The cell line, gene, and protocol effect
was the only random effect in the log2-ratio that was de-
pendent on the amplification protocol. This indicates that
the noise due to amplification was low.
The SNR-criterion for the conservative data set is present-
ed in Table 4. Inclusion of the cell line, gene, and protocol
effect only reduced the SNR slightly from 5.38 to 5.30. We
therefore conclude that the ratios for the genes in the
"conservative set" seem to be preserved by the amplifica-
tion protocol. This is in compliance with the results of the
t-tests.
The SNR for the "conservative set" without σCGP was clear-
ly lower than the SNR for the total set of genes. This result
may have several explanations. One is that the total set of
Table 3: Parameter estimates for the total data set consisting of 10759 genes and for the "conservative set" of 2721 genes.
Parameter Type of effect1 Estimate Total set Estimate Conserved set
µ Fixed 10.56 12.18
C (cell line 2; U2OS) Fixed 0.086 -0.028
D (Cy3) Fixed -0.026 -0.022
P (non-amplified) Fixed -0.74 -1.14
CP22 (cell line 2 and non-amplified) Fixed -0.0043 0.0089
σA (array) Random 0.28 0.30
σB (batch) Random 0.041 0.041
σC (gene) Random 1.36 0.98
σAD Random 0.039 0.040
σGP Random 0.85 0.79
σCG Random 0.74 0.54
σAG Random 0.44 0.44
σDG Random 0.048 0.050
σCGP Random 0.22 0.028
σε Random 0.22 0.22
Annotations: µ = overall mean signal intensity, C = cell line type, D = labeled dye, P = protocol. 1 Of the fixed effects, C, D, and P have two levels 
while CP is an interaction between two fixed effects. The random effects were modeled as independently normally distributed random effects with 
zero mean and constant standard deviation. σCGP is the cell line specific GP effect and is the effect of primary interest.
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(A) Plot of the difference in log2-ratio between the amplified and the non-amplified material for the log2-ratio of the two cell-
lines (MT-1, U2OS) vs. the p-value for each of the 4331 genes, calculated for hypothesis testing. (B) Plot of the average log2-
ratio of the two cell-lines (MT-1 and U2OS), for the amplified and the non-amplified material for each of the 4331 genes inves-
tigated during hypothesis testing. The genes in the "conservative set" are in green, the genes in the "rejected set" are in red and 
the genes in the "undetermined set" are in black.Page 7 of 13
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tensity than the ones in the conservative set. This is sup-
ported by the fact that both G and CG were lower in
the "conservative set".
Assessing the percentage of genes where the ratio was 
preserved
For the data set under study (i.e. for the genes on our ar-
rays, using the explained hybridization protocol, with our
choice of scanning procedure, filtering and normaliza-
tion), we found that the variability caused by amplifica-
tion was substantial and the ratios seem not to be
preserved. We found a "conservative set" of the genes
where the variability caused by amplification was small,
and the ratios seem to be preserved. Estimating the per-
centage of genes where the ratio was not preserved by the
amplification protocol was difficult. Different strategies
could be employed, but the validity of the assumptions
underlying the different strategies is hard to check proper-
ly. If we believe that the assumptions underlying the two-
sample t-test performed are true, based on the distribution
of the p-values it is possible to estimate the number of true
null-hypotheses (i.e. the number of genes where the ratio
is preserved). Assuming that the test-statistics underlying
the two-sample t-test were independent across genes and
using the estimator of Schweder and Spjøtvoll [21], the
number of genes with unchanged ratios was of the order
64%. Another strategy is to look at the percentage of genes
not rejected at the level 5% of false discovery rate. This
number was 90%. Turning this number around we could
say that 10% of the genes showed significantly different
expression when comparing amplified with non-ampli-
fied material. As an indication of the robustness of these
findings we assessed the number of genes not rejected at
the level 5% of false discovery rate when comparing two
groups of arrays with amplified material. Comparing two
groups of arrays with amplified material, we would expect
the ratios between the two cell lines to be the same for
both groups for all genes. In our data set there are eight ar-
rays with amplified material, and there are 35 ways of di-
viding these arrays into two groups of four arrays each.
Analysing these 35 data sets using multiple hypothesis
testing the overall result was that 0.04% of the genes
(compared to 10% for amplified vs. non-amplified) were
found to show different expression ratios between the two
cell lines for the two groups at a false discovery rate of 5%.
This finding is in agreement with what was expected.
Aspects of the results
In order to obtain reliable information from expression
data from amplified material, it is important to be aware
of how the amplification procedure may affect the data.
By comparing expression data between amplified and
non-amplified material, we have observed that the ratios
were significantly different for a number of genes, in addi-
tion to a set of genes whose ratios were neither conserved
nor rejected.
Although significant differences between ratios for a sub-
set of genes was expected due to the nature of variability
in microarray experiments, we examined whether there
was a systematic skewing of the data by investigating mo-
lecular properties of the probes printed on the arrays.
We mapped the clone sequences of the genes to their ref-
erence mRNA sequence (RefSeq). Based on this mapping,
we examined the GC content of the clones and of the re-
maining stretch between the 3' end of the clone to the
poly (A) tail of corresponding mRNA. If the distribution
of the GC content was different for the genes in the
"conservative set" compared to the genes in the "rejected
set" and "undetermined set", this could indicate that opti-
mization in the form of increased temperatures during
strand synthesis may be an improvement of the amplifica-
tion protocol. Increased temperatures have been
emphasized in certain publications [4,13]. We were able
to match 40–50% of the clones under investigation with
their corresponding mRNA sequence. For the 4331 genes
for which ratio and p-values were calculated, the GC con-
tent displayed the same distribution in all subsets, "con-
servative ", " rejected", and "undetermined " (data not
shown). This was also true for the set of genes with ratios
obtained only from arrays with amplified material (4377
genes). Hence, there was no apparent bias towards se-
quences with low GC content during the amplification
procedure.
Table 4: Signal to Noise Ratio (SNR) for the two data sets.
Data set SNR without σCGP SNR with σCGP
Total set1 9.91 5.22
Conservative set2 5.38 5.30
1The total data set included 10579 genes detected on at least one of the twelve arrays. 2The conservative data set included genes found to have 
equal ratio expression between amplified and non-amplified material. σCGP is the cell line specific GP effect and is the effect of primary interest.
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volving several polymerases synthesizing new strands, we
were also interested in the position of the printed clones
relative to the poly(A) tail. We knew that during amplifi-
cation [10], the RNA transcripts were systematically re-
duced in length and were on the average 400–450 bp
(data not shown), in addition to being 3' end biased due
to the use of an oligo dT-primer. The question was wheth-
er the array probes that were positioned far from the poly
(A) tail had an equal chance of being hybridized to la-
beled cDNA synthesized from both aRNA products and
total RNA. We found that the average length of the printed
clones was the same for all subgroups of genes mentioned
above (data not shown), and the distance from the poly
(A) sequence to the 3' end of the clones was also distrib-
uted evenly throughout the subgroups. The majority of
the clones were 3' end biased. For a large fraction, the dis-
tance from the poly (A) tail to the 3' end was 0 bp. As there
is a 3' end bias in the clone set, a drift away from the po-
ly(A) tail caused by random priming in the second round
of amplification could possibly affect the preservation of
ratios. As the transcripts are reduced in length during the
initial round of amplification, due to priming with an-
chored oligo dT, it is a reasonable assumption that a drift
is more likely to affect ratio preservation of longer mRNA
transcripts. However, this possibility seems to be less im-
portant, as the use of random priming does not appear to
introduce variation between replicated amplifications.
This is supported by the highly correlated array data when
comparing aRNA samples generated from the same start-
ing material.
One important feature of the amplified protocol was the
increased total intensity on the arrays. The absolute inten-
sity was doubled compared to standard total RNA experi-
ments. One main difference is that 3 µg aRNA (used in
labeling reaction) corresponds to approximately ten times
more than 30 µg total RNA. Using equivalent amount of
total RNA (300 µg) requires a substantial RNA source and
is unrealistic in most experiments. Another difference was
the high degree of purity of aRNA compared to total RNA
as measured by optical density (2.4 versus 1.9). Greater
purity implies reduced number of disturbing factors dur-
ing the labeling reaction. In agreement with previous re-
ports [13,14], we retained a considerably larger number of
transcripts through the amplification protocol. After filter-
ing procedures (see Table 1), 4377 genes were exclusively
left in the amplified data set. We also observed that the av-
erage signal intensity for these 4377 gene transcripts was
lower than for the amplified transcripts in the 4331 gene
subset (with at least three observations per gene in each
group of arrays (amplified and non-amplified). Hu et al.
[14] suggested that this is due to improvement of signal
intensities of genes with low transcript numbers.
Compared to total RNA, hybridizations performed with
aRNA generally provide superior Signal to Noise Ratio
even for genes with low expression. In addition aRNA pro-
vides highly reproducible results and may in some situa-
tions give a better representation of the true transcript
abundance than using total RNA. However, it is a plausi-
ble assumption, though not presently thoroughly tested,
that a reduced Signal to Noise Ratio will result from in-
creasingly lower sample start material for global mRNA
amplification procedures. This will be a consequence of
larger stochastic variation for transcripts of lower copy
numbers. To distinguish which approach is the closest to
the true standard, a detailed comparison of results ob-
tained from experiments in a dilution series, or by other
molecular techniques, including real time PCR or SAGE,
may be warranted. These considerations also apply for
similar methods, such as the recently introduced method
of exponential amplification of transcripts by PCR, rather
than amplification through in vitro transcription [17,22].
Conclusions
The present work has utilized a quantitative approach to-
wards evaluating mRNA amplification procedures. Under
the experimental conditions applied, we found that the
impact of amplification was increased noise in the form of
ratio distortions for some genes. We did not find that mo-
lecular properties of the clones could be used as a predic-
tion of unfaithful ratio preservation. More than half of the
genes in the undetermined group (27% of the 4331 gene
subset), had a log2-ratio difference within the range of +/
- 0.5. Distinguishing between genes that are truly ex-
pressed differently and genes that are simply affected by
various sources of noise remains a challenge. Caution may
therefore be necessary when interpreting results obtained
from amplification procedures. In further studies, the
same analysis set-up permits determination of the sensi-
tivity level of the amplification procedure by assessing the
effect of reducing the amount of total RNA in the first
round of aRNA production. This will be useful in order to
extract informative gene expression data from extremely
limited cell samples.
Methods
cDNA arrays
The microarrays used in this paper were produced in
house using a Micro Grid II robotic printer (Bio Robotics,
Cambridge, UK). These 13 k human cDNA arrays were
printed on amino silane coated slides (CMT GAPS, Corn-
ing Life Sciences, Corning, NY). For details on the arrays,
we refer to: http://www.med.uio.no/dnr/microarray/in-
dex.html.
RNA purification
RNA from two cell lines, MT-1 (human breast cell line,
kindly provided by Dr. I Fitchner, (Naundorf et al. [23])Page 9 of 13
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MD), were used in all experiments. The cell lines were
maintained in RPMI media (Bio Whittaker Europe)
supplemented with 10% fetal calf serum (PAA Laborato-
ries, Linz, Austria). The cell cultures were grown without
antibiotics and tested negative for mycoplasma infection.
Total RNA was isolated using GenElute Mammalian Total
RNA kit (Sigma, St. Louis, MO) according to the manufac-
turer's protocol. RNA concentrations were determined by
OD260 reading in 50 mM NaOH (GeneQuant, Amersham
Pharmacia Biotech AB, Uppsala, Sweden). Total RNA
from the respective cell lines were aliquoted to 30 µg total
RNA per sample. In addition, an aliquot of RNA from
each cell line was diluted to 1 µg/ul total RNA concentra-
tion and further down to 0.1 µg/ul.
RNA amplification
RNA amplification was carried out as published by Baugh
et al. [5] though slightly modified. The modifications
mainly involved a different choice of enzyme in respect to
the original protocol. A detailed version of the protocol
can be found at the following website: http://
www.med.uio.no/dnr/microarray/
Mat_and_met_amp.pdf. Briefly, the initial amount of to-
tal RNA used for all amplifications was 0.2 µg and all sam-
ples went through two rounds of amplification. In a 10 µl
reverse transcription reaction, 0.2 µg total RNA was tran-
scribed by priming with a dT/T7-primer. Second strand
synthesis was initiated by RNase digestion. The purified
double stranded cDNA served as the template for the first
round of in vitro aRNA transcription. For the subsequent
round of amplification, the first strand cDNA was primed
with random hexamers. The synthesis of the second
strand was initiated by annealing a dT/T7-primer to the
aRNA:cDNA heteroduplex with partially digested aRNA.
After purification, a second round of in vitro transcription
followed.
RNA labeling
Three µg of aRNA and 30 µg of total RNA was labeled with
Cy3- or Cy5-labeled dCTP (Amersham Pharmacia Biotech
AB) during reverse transcription. The reaction mixture
consisted of random hexamers (16 µg) or anchored oligo-
dT 20-mer primers (4 µg) depending on whether aRNA or
total RNA was labeled. Further, 40 U RNAsin (Promega,
Madison, WI), 1st strand buffer, 0.1 M DTT, 0.5 mM of
dATP, dCTP, dGTP and 0.2 mM dTTP was added and the
mix was incubated for 5 min at 65°C in a water bath. The
tube was then transferred to a heating block (42°C), and
4 µl of either fluorophore was added to the respective
tubes followed by 400 U SuperScript II (Invitrogen, Gron-
ingen, The Netherlands). After 60 min the reaction was
stopped by adding 5 µl 0.5 M EDTA (pH = 8.0). Residual
RNA was hydrolyzed with 10 µl 1 M NaOH and incubated
at 65°C for either 60 or 15 min depending on whether to-
tal RNA or aRNA was reverse transcribed. Twenty-five µl 1
M Tris-HCl (pH 7.5) was added to neutralize the mixture.
Micro Bio-Spin columns, P-6 (Bio-Rad Laboratories, Her-
cules, CA) were used to remove unincorporated dye. La-
beled Cy3- and Cy5-cDNA was respectively diluted with
TE-buffer (pH 7.5) before Microcon YM-30 columns (Am-
icon, Millipore Corporation, Bedford, MA) were applied
to concentrate the samples to 17–20 µl.
Hybridization and scanning
The hybridization volume of 40 µl consisted of 17 µl of
each of the labeled probes, 3.5 × SSC (pH = 7.5), 0.3%
SDS, 1.25 × Denhardt's solution, 4 µg yeast tRNA, and 4
µg BSA. Additionally, 16 µg poly A (Amersham Pharmacia
Biotech AB) was used if the probe was based on total RNA.
The final mix was heated for 2 min at 100°C and spun
down for 10 min at 13 K before it was applied on a micro-
array slide under the LifterSlip (Erie Scientific Company,
Portsmouth, NH). The slide was then placed in an ArrayIT
hybridization chamber (Telechem, Sunnyvale, CA) and
submersed into a water bath for over night hybridization
at 65°C. Prior to scanning, the coverslip was removed in
a solution of 2 X SSC and 0.1% SDS, and the slide was
washed in the following solutions for 5 min at room tem-
perature; 1 X SSC, 0.2 X SSC and 0.05 X SSC. The slide was
dried by centrifugation. Scanning was performed with a
ScanARRAY 4000 (Packard Biosciences, Biochip Technol-
ogies LLC, Meriden, CT) scanner, and data was acquired
from the images using GenePix Pro 3.0 software (Axon In-
struments Inc., Union City, CA). A background-corrected
intensity for each spot was formed by subtracting the
mean of the pixels in the local background from the mean
of the pixels in the spot.
Description of experiments
To avoid variability due to total RNA preparation, we
pooled purified total RNA into a single large sample for
each of the two RNA sources, the MT-1 and U2OS cell
lines. The RNAs used in the experiments were based on
these two initial samples. Aliquots from the initial sample
represented a batch and there were six batches per cell
line. Two of these batches were directly labeled in
duplicated experiments using a dye swap strategy, while
the remaining 4 diluted batches were used as starting ma-
terial for independent, parallel amplifications. Corre-
sponding pairs of aRNA, aRNA (MT-1) and aRNA
(U2OS), were labeled and co-hybridized in duplicated ex-
periments using (again) a dye swap strategy. Thus, in total
there were 4 data sets based on non-amplified RNA and 8
based on amplified RNA. The microarray slides were all
from the same print batch. Since it is impossible to hy-
bridize non-amplified and amplified material on the
same array, we chose to use two different cell lines on each
microarray.Page 10 of 13
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From the data for each microarray we first manually re-
moved technically flawed spots. Then spots automatically
flagged by the GenePix software were removed. Finally, all
spots where the spot intensity (uncorrected foreground
intensity) was lower than twice the background intensity
in any of the two channels were removed (i.e. ((spot-back-
ground)/background) < 1). An overview of the number of
filtered genes is given in Tables 1 and 2.
Systematic errors were corrected by normalizing the data
using the locally weighted scatterplot smoother, lowess, as
described in Yang et al. [24] and implemented in the sma
package in the statistical language R. This routine normal-
ized the ratios for each spot on each array by subtracting a
value s, depending on the value of the log2-transformed
total intensity of the spot on the array. In addition we nor-
malized log2-transformed intensities by adding the value
s/2 to the log2-transformed intensity of the Cy3 (green)
channel and subtracting the value s/2 from the log2-trans-
formed intensity of the Cy5 (red) channel. This normali-
zation of intensities was done because the ANOVA model
is based on log2-transformed intensities.
Analysis of variance modeling
The first step in the ANOVA modeling is to evaluate the
sources of variability present, and their interactions. The
next step is to construct the model and experimental de-
sign accordingly. We identified the following 6 main ef-
fects or factors for the design:
-We used 12 different microarrays (A).
-There were 2 cell lines (C).
-Each cell line was divided into 6 batches, giving a total of
12 batches (B).
-The material was labeled red (Cy5) or green (Cy3), so the
dye (D) effect had 2 levels.
-The material was amplified on 8 of the microarrays and
not amplified on the other 4, i.e. two levels for the proto-
col (P) effect.
-A total of 10759 genes (G) remained after filtering (these
genes were present on at least one microarray).
Figure 1 presents an overview of the experimental design.
For a particular cell line, the material was divided into 6
batches. These batches were split in two and labeled Cy5
(red) or Cy3 (green). The design is not balanced, since we
chose to use twice as many microarrays with amplified
material, but we wanted to be able to handle the possibil-
ity that each amplification event induced a larger variabil-
ity between the arrays with amplified material than
between the arrays with the non-amplified material.
Statistical model for the ANOVA analyses
To investigate the different sources of variability, we set up
an ANOVA-based statistical model. Related models are
found in Kerr et al. [25], Wolfinger et al. [26] and Jin et al.
[27]. Let log2 yijklmn denote the log2-transform of the nor-
malized measured intensity on array i, for cell line j, for
batch k, using dye l and protocol m for gene n. We explain
the log2-transformed intensity by the following model:
log2 yijklmn = µ + Ai + Cj + Bk + Dl + Pm + Gn
+ADil + CPjm + GPnm + CGjn + AGin + DGln +
CGPjnm + εijklmn,
with i = 1,...,12, j = 1,2, k = 1,...,12, l = 1,2, m = 1,2, n =
1,...,10759, where µ is the overall mean, Ai is the overall
array effect on array i, Cj is the overall cell line effect of
cell-line j, Bk is the overall batch effect of batch k, Dl is the
overall dye effect of dye l, Pm is the overall effect of the am-
plification protocol and Gn is the overall gene effect of
gene n. Furthermore, ADil is the interaction between array
and dye, so if this effect is significant, the dye has different
effect for different arrays. CPjm models different effect of
amplification on different cell lines. GPnm is of significant
size if the amplification protocol has a different effect on
different genes and CGjn represents the gene-specific cell
line effect. This is usually an effect of interest e.g. if we
want to measure different expression for the two cell lines
for each gene. AGin is the spot effect, it models variation in
the amount of cDNA deposited in each spot during the
printing process. DGln represents the gene-specific dye ef-
fect. CGPjmn is the cell line specific GPnm effect, and is our
interaction of primary interest.
Only the cell line effect (Cj), the dye effect (Dl), the proto-
col effect (Pm) and the cell line protocol interaction (CPjm)
were modeled to be fixed effects (the first three have only
two levels and the last is a combination of two fixed
effects). CPjm is confounded with Cj and Pm, so we only es-
timated CP22. All other effects were modeled as
independent normally distributed random effects with
zero mean and constant standard deviation. This means
that Ai ~ N(0, ), Bk ~ N(0, ), and similarly for all the
other random effects. εijklmn is the modeling and measure-
ment error, and it was also assumed to be normally dis-
tributed, εijklmn ~ N(0, ). This is a mixed-effects model,
since some of the effects are fixed and others are random.
We were interested in the preservation of the ratios after
amplification and used the model for the log2-trans-
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the ratio of cell line 1 and cell line 2 for each spot on each
array. Considering a randomly chosen spot, we wrote the
observation of cell line 1 (j = 1) as log2 yijklmn and cell line
2 (j = 2) as log2 yijk'l'mn (the same array, i, was used, the
same protocol, m, was used, it was the same gene, n, but
batch, k and k', and dye, l and l', were different). The ef-
fects that were equal for each spot cancelled when looking
at the ratio:
We wanted to see how the overall signal was affected by
an amplification protocol that possibly did not fully pre-
serve the ratios. The signal we are usually interested in is
the gene expression using a specific cell type for a specific
gene, i.e. CGjn. The Signal to Noise Ratio (SNR) is a valu-
able measure for answering this question. The SNR is de-
fined as signal divided by noise. CGjn is the signal and the
other effects are noise. Using the expression for the ratios,
we see that the variance of the ratio of interest is
(the variance for the fixed effects are VAR(Cj) = VAR(Dl) =
VAR(CPjm) = 0) so the Signal to Noise Ratio is
By comparing the Signal to Noise Ratio with and without
the CGPjmn interaction present in the model, we were able
to see how large impact amplification had on the signal.
Hence, we estimated the parameters in the ANOVA mod-
el, and used the parameters estimated for the random ef-
fects to form the SNR to be investigated.
Due to the large dimensions in the mixed-effects model,
we estimated the parameters of interest (the fixed effects
and the variances of the random effects) using Gibbs-sam-
pling. Gibbs-sampling is an iterative simulation method,
which was run on the computer to provide our parameter
estimates. We refer to the web page http://www.nr.no/
documents/samba/research_areas/SMBI/NAR/ for details.
Hypothesis testing
Preservation of ratios can be addressed by performing hy-
pothesis testing by comparing ratios between the two cell
lines for the amplified material with ratios between the
two cell lines for the non-amplified material for each
gene. We have used this strategy as a complement to our
preferred ANOVA-based procedure. Let νn(1) be the ex-
pected log2-ratio between the two cell lines for the non-
amplified material for gene n, and let νn(2) be the expected
log2-ratio between the two cell-lines for the amplified ma-
terial for gene n. We wanted to test the following hypoth-
esis for each gene n.
H0n: νn(1) = νn(2) vs H1n: νn(1) ≠ νn(2)
Many methods for performing hypothesis testing exist,
and we chose to use a two-sample t-test for each gene sep-
arately. Thus, we estimated the variability for each gene in
each group of samples separately, amplified and non-am-
plified (allowing the variability for the amplified samples
to be different from the variability for the non-amplified
sample). The Smith-Welch-Satterthwaite approximation
to the degrees of freedom in the two-sample t-test was
used, see any introductory statistical text e.g. Walpole, My-
ers and Myers [28], chapter 10.8.
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